Home » Topics » Regulatory

Regulatory
RSS

Company Profile: Celgene Corporation

Dec. 30, 1996

Novel antihistamine formulation approved by FDA

Dec. 24, 1996

NanoSystems to develop novel formulation of HIV protease inhibitor

Dec. 23, 1996

First Rx for oral ulcers cleared by FDA

Dec. 23, 1996

Schering-Plough claims novel use for Flt3 ligand

Dec. 23, 1996

Takeda claims new treatments for pancreatitis

Dec. 23, 1996

Regeneron claims novel use for neurotrophic factor

Dec. 23, 1996

Spray formulation of antimigraine Rx cleared for marketing

Dec. 20, 1996

Advisory committee recommends approval of non-nicotine smoking cessation product

Dec. 13, 1996

First marketing approval for Allergan antipsoriatic

Dec. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 11, 2025.
Deep Apple signs big Novo deal for cardiometabolic small molecules
BioWorld
Deep Apple Therapeutics Inc. could bring in as much as $812 million in a new collaboration and license deal with Novo Nordisk A/S. The total includes an...
23andme genetic privacy concerns garner Congressional scrutiny
BioWorld MedTech
The bankruptcy of genetic testing service 23andme Holding Corp. prompted a reaction from many quarters, but a June 11 Senate hearing highlighted an interest in...
3Sbio revs on with phase II data in tight PD-1/VEGF bispecific race
BioWorld
3Sbio Inc. reported interim phase II study results of its PD-1/VEGF bispecific antibody, SSGJ-707 – a “fabulous” asset, according to Pfizer Inc. CEO Albert...